Titlebook: Advances in Cancer Survivorship Management; Lewis E. Foxhall,Maria Alma Rodriguez Book 2015 The University of Texas M. D. Anderson Cancer

LUDE

bourgeois

Book 2015ly estimated to be 12 million in the United States and more than 25 million worldwide.?As cancer survival rates have increased, it has slowly become clear that the challenges faced by people with cancer do not end with treatment but simply change. This book aims to assist community oncologists, phys

frozen-shoulder

adult survivors of pediatric cancers.Primary prevention andThis volume presents the MD Anderson experience in providing care and services to the rapidly growing population of cancer survivors, which is currently estimated to be 12 million in the United States and more than 25 million worldwide.?As

tattle

FLING

978-1-4939-0985-8The University of Texas M. D. Anderson Cancer Center 2015

archetype

Alan Simson,Silvija Krajter Ostoi?ed long-term survivors. The number of cancer survivors in the United States is now estimated to be nearly 13 million (approximately 4 % of the population), and the number is continually growing. The chapters discuss survivorship of numerous types of cancer as well as lifestyle, legal, and communicat

不斷的變動(dòng)

Hongxiu Li,Pirkko Nyk?nen,Ming Zhanbeyond treatment. For each of these three phases, survivors have different health care needs. A report issued in 2005 by the Institute of Medicine, entitled “From Cancer Patient to Cancer Survivor: Lost in Transition,” brought to light the problems that many cancer survivors face once they are past

一瞥

Tactile Maps - Safety and Usabilitybut the primary components of care include surveillance for recurrence, screening for second primary cancers, and primary prevention involving lifestyle interventions and improving psychosocial functioning. The goal of survivorship care is to maximize disease-free survival while maintaining optimal

發(fā)誓放棄

使堅(jiān)硬

Tactile Maps - Safety and Usabilityecades. This chapter will focus on MD Anderson’s recommendations for surveillance and treatment in breast cancer survivors. Because randomized trials have not demonstrated a survival benefit with intensive monitoring, current guidelines support the use of medical history review, physical examination